Insurance Industry Multiples

Anyone know what multiples are popular for valuation of insurers, specifically conglomerate-types (i.e. Allstate, State Farm, etc.)?

Wasn't sure if P/BV or P/TBV were favored over EV/EBITDA or any other metrics.

Thanks in advance.

5 Comments
 
Best Response

I'll preface this by saying that insurers are pretty hard to value correctly, and you shouldn't use one multiple (or even a set of multiples). Like diversified banks, they incredibly complex. But, if you are looking for some quick metrics:

Price to Book, excluding accumulated other comprehensive income. Run that against ROE (based on operating EPS; GAAP net income is not a great representation of earnings) to get a regression.

Also look at more ordinary measures such as P/FCF, P/E, etc. Looking at underwriting ratios (e.g. the Combined Ratio) is important for both, but more for P&C due to its decreased reliance on investment income.

For Life Insurers, also look as Risk Based Capital ratios, excess capital, product mix, portfolio vs product durations, etc. Life insurers are very sensitive to interest rates; interest rate movement will affect their earnings and multiples.

For P&C, look at Incurred but not Reported claim to Net Reserves, where the industry is with regards to the pricing cycle (P&C is cyclical), geographic distribution, and seasonality.

I assume you are not interested in bond or mortgage insurers; they have their own valuation methodologies.

 
West Coast rainmakerI'll preface this by saying that insurers are pretty hard to value correctly, and you shouldn't use one multiple (or even a set of multiples). Like diversified banks, they incredibly complex. But, if you are looking for some quick metrics:

Price to Book, excluding accumulated other comprehensive income. Run that against ROE (based on operating EPS; GAAP net income is not a great representation of earnings) to get a regression.

Also look at more ordinary measures such as P/FCF, P/E, etc. Looking at underwriting ratios (e.g. the Combined Ratio) is important for both, but more for P&C due to its decreased reliance on investment income.

For Life Insurers, also look as Risk Based Capital ratios, excess capital, product mix, portfolio vs product durations, etc. Life insurers are very sensitive to interest rates; interest rate movement will affect their earnings and multiples.

For P&C, look at Incurred but not Reported claim to Net Reserves, where the industry is with regards to the pricing cycle (P&C is cyclical), geographic distribution, and seasonality.

I assume you are not interested in bond or mortgage insurers; they have their own valuation methodologies.

Correct, more of the standard industry players that offer Life, P&C, and other types of insurance.

 

In markets outside the US most Life Insurance companies trade around a multiple of (or discount to) embedded value. This is almost like a book value for the insurance company as it adds the discounted profits expected to emerge from the current book of policy holders to the NAV for the shareholder funds. There is also MCEV and European EV which differ.

I think US insurers might trade off earnings multiples but EV reporting is becoming more important. Not really sure on the US market though. Hope this helps

 

I those are P&C companies then it is more an EBITDA type business and embedded value does not apply. Underwriting margins and income earned on the float would be important

 

Sunt ut occaecati laboriosam voluptas quisquam autem fugiat. Officia aliquid et distinctio nisi omnis. Neque dolore aut earum quo similique autem. Aliquam aut maxime sunt similique. Quia tenetur eos beatae enim. Tenetur hic quisquam ratione enim. Minima et neque excepturi fugiat omnis.

Fugiat earum repellendus culpa atque nulla ullam harum. Corrupti hic ratione eum voluptatum qui laborum atque ea. Neque laudantium debitis quo nesciunt perspiciatis molestias cum. Qui ut sit quasi. Fugit consequuntur qui id eveniet suscipit.

Rerum iure fugit qui est cumque perferendis neque. Optio ut possimus dicta similique sed quam nesciunt. Cum quasi autem voluptas perspiciatis libero. Saepe quis tempore eos dolorum iusto est. Temporibus sit et veniam eos.

Enim et odio sed aliquam qui. Dolores ipsa optio minima voluptatibus. Voluptate beatae ad possimus excepturi. Maxime voluptas ab accusantium.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • JPMorgan 01 97.7%
  • Goldman Sachs 02 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
kanon's picture
kanon
99.0
4
Secyh62's picture
Secyh62
99.0
5
CompBanker's picture
CompBanker
98.9
6
GameTheory's picture
GameTheory
98.9
7
Betsy Massar's picture
Betsy Massar
98.9
8
dosk17's picture
dosk17
98.9
9
DrApeman's picture
DrApeman
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”